United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Transcenta gets US FDA clearance for launching phase 1 trial of TST005 Transcenta has secured clearance of its investigational new drug (IND) application for TST005 from the US Food and Drug… bySrinathApril 20, 2021
